Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Masood Alam Khan, Ajamaluddin Malik, Abdulmohsen M. Alruwetei, Mohammad A. Alzohairy, Bader Y. Alhatlani, Osamah Al Rugaie, Fahad A. Alhumaydhi & Arif Khan. (2022) Delivery of MERS antigen encapsulated in α-GalCer-bearing liposomes elicits stronger antigen-specific immune responses. Journal of Drug Targeting 30:8, pages 884-893.
Read now
Read now
Liping Li, Jing Yang, Lihua Ren, Ning Su, Yichuan Fang & Yi Lin. (2013) Invariant NKT cells increase lipopolysacchride-induced pregnancy loss by a mechanism involving Th1 and Th17 responses. The Journal of Maternal-Fetal & Neonatal Medicine 26:12, pages 1212-1218.
Read now
Read now
Articles from other publishers (26)
Federico Riu, Alessandro Ruda, Roberta Ibba, Simona Sestito, Ilenia Lupinu, Sandra Piras, Göran Widmalm & Antonio Carta. (2022) Antibiotics and Carbohydrate-Containing Drugs Targeting Bacterial Cell Envelopes: An Overview. Pharmaceuticals 15:8, pages 942.
Crossref
Crossref
Masood Alam Khan, Arif Khan, Mohammad A. Alzohairy, Abdulmohsen M. Alruwetei, Mohammed A. Alsahli, Khaled S. Allemailem, Faris Alrumaihi, Ahmad Almatroudi, Bader Y. Alhatlani, Osamah Al Rugaie & Ajamaluddin Malik. (2022) Encapsulation of MERS antigen into α-GalCer-bearing-liposomes elicits stronger effector and memory immune responses in immunocompetent and leukopenic mice. Journal of King Saud University - Science 34:5, pages 102124.
Crossref
Crossref
Farjana Khatun, Istvan Toth & Rachel J. Stephenson. (2020) Immunology of carbohydrate-based vaccines. Advanced Drug Delivery Reviews 165-166, pages 117-126.
Crossref
Crossref
Samuel Golten, Allan Patinec, Katy Akoumany, Jézabel Rocher, Jérôme Graton, Denis Jacquemin, Jean-Yves Le Questel, Arnaud Tessier, Jacques Lebreton, Virginie Blot, Muriel Pipelier, Jean-Yves Douillard, Jacques Le Pendu, Bruno Linclau & Didier Dubreuil. (2019) 3,4-Dideoxy-3,3,4,4-tetrafluoro- and 4-OH epimeric 3-deoxy-3,3-difluoro-α-GalCer analogues: Synthesis and biological evaluation on human iNKT cells stimulation. European Journal of Medicinal Chemistry 178, pages 195-213.
Crossref
Crossref
Ana Caroline Colombo, Antonella Rella, Tyler Normile, Luna S. Joffe, Patricia M. Tavares, Glauber R. de S. Araújo, Susana Frases, Erika P. Orner, Amir M. Farnoud, Bettina C. Fries, Brian Sheridan, Leonardo Nimrichter, Marcio L. Rodrigues & Maurizio Del Poeta. (2019)
Cryptococcus neoformans
Glucuronoxylomannan and Sterylglucoside Are Required for Host Protection in an Animal Vaccination Model
. mBio 10:2.
Crossref
Crossref
Qianhui Chen, Xuxue Guo, Nishan Deng, Linlin Liu, Shuo Chen, Ailing Wang, Ruiyun Li, Yi Huang, Xuhong Ding, Hongying Yu, Suping Hu & Hanxiang Nie. (2019) α-Galactosylceramide treatment before allergen sensitization promotes iNKT cell–mediated induction of Treg cells, preventing Th2 cell responses in murine asthma. Journal of Biological Chemistry 294:14, pages 5438-5455.
Crossref
Crossref
Marley C. Caballero Van Dyke & Floyd L. WormleyJrJr. (2018) A Call to Arms: Quest for a Cryptococcal Vaccine. Trends in Microbiology 26:5, pages 436-446.
Crossref
Crossref
Pragya Rampuria & Mark L. Lang. 2018. Immunology. Immunology
55
73
.
Srinivasa Reddy Bonam, Charalambos D. Partidos, Sampath Kumar M. Halmuthur & Sylviane Muller. (2017) An Overview of Novel Adjuvants Designed for Improving Vaccine Efficacy. Trends in Pharmacological Sciences 38:9, pages 771-793.
Crossref
Crossref
Luc Van Kaer, Vrajesh V. Parekh & Lan Wu. (2015) The Response of CD1d-Restricted Invariant NKT Cells to Microbial Pathogens and Their Products. Frontiers in Immunology 6.
Crossref
Crossref
AK Singh, P Gaur, NK Shukla & SN Das. (2014)
Differential dendritic cell‐mediated activation and functions of invariant
NKT
‐cell subsets in oral cancer
. Oral Diseases 21:1.
Crossref
Crossref
Aine E. Abautret-Daly, Christopher J.H. Davitt & Ed C. Lavelle. (2014) Harnessing the antibacterial and immunological properties of mucosal-associated invariant T cells in the development of novel oral vaccines against enteric infections. Biochemical Pharmacology 92:2, pages 173-183.
Crossref
Crossref
Josianne Nitcheu Tefit, Sandrine Crabé, Bernard Orlandini, Haylene Nell, Albert Bendelac, Shenglou Deng, Paul B. Savage, Luc Teyton & Vincent Serra. (2014) Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination. Vaccine 32:46, pages 6138-6145.
Crossref
Crossref
Aline Banchet-Cadeddu & Arnaud Haudrechy. (2014) From d-xylose to a d-glycero-l-altrose derivative. Tetrahedron Letters 55:33, pages 4605-4607.
Crossref
Crossref
Xavier Laurent, Benjamin Bertin, Nicolas Renault, Amaury Farce, Silvia Speca, Ophélie Milhomme, Régis Millet, Pierre Desreumaux, Eric Hénon & Philippe Chavatte. (2014) Switching Invariant Natural Killer T (iNKT) Cell Response from Anticancerous to Anti-Inflammatory Effect: Molecular Bases. Journal of Medicinal Chemistry 57:13, pages 5489-5508.
Crossref
Crossref
Liping Li, Lijuan Shi, Xinying Yang, Lihua Ren, Jing Yang & Yi Lin. (2013) Role of invariant natural killer T cells in lipopolysaccharide-induced pregnancy loss. Cellular Immunology 286:1-2, pages 1-10.
Crossref
Crossref
Anna Bershteyn, Melissa C. Hanson, Monica P. Crespo, James J. Moon, Adrienne V. Li, Heikyung Suh & Darrell J. Irvine. (2012) Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine. Journal of Controlled Release 157:3, pages 354-365.
Crossref
Crossref
Marloes A. Naarding, Emilia Falkowska, Hui Xiao & Tatjana Dragic. (2011) Hepatitis C virus soluble E2 in combination with QuilA and CpG ODN induces neutralizing antibodies in mice. Vaccine 29:16, pages 2910-2917.
Crossref
Crossref
Aline Banchet-Cadeddu, Agathe Martinez, Stéphane Guillarme, Véronique Parietti, Fanny Monneaux, Eric Hénon, Jean-Hugues Renault, Jean-Marc Nuzillard & Arnaud Haudrechy. (2011) Use of the NEO strategy (Nucleophilic addition/Epoxide Opening) for the synthesis of a new C-galactoside ester analogue of KRN 7000. Bioorganic & Medicinal Chemistry Letters 21:8, pages 2510-2514.
Crossref
Crossref
Luc Van Kaer, Vrajesh V Parekh & Lan Wu. (2011) Invariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigens. Immunotherapy 3:1, pages 59-75.
Crossref
Crossref
Godfrey Getz, Paul VanderLaan & Catherine Reardon. (2017) Natural killer T cells in lipoprotein metabolism and atherosclerosis. Thrombosis and Haemostasis 106:11, pages 814-819.
Crossref
Crossref
Aline Banchet-Cadeddu, Eric Hénon, Manuel Dauchez, Jean-Hugues Renault, Fanny Monneaux & Arnaud Haudrechy. (2011) The stimulating adventure of KRN 7000. Organic & Biomolecular Chemistry 9:9, pages 3080.
Crossref
Crossref
Luc Van Kaer, Vrajesh V. Parekh & Lan Wu. (2010) Invariant natural killer T cells: bridging innate and adaptive immunity. Cell and Tissue Research 343:1, pages 43-55.
Crossref
Crossref
Niamh Murphy, Xiangming Zhu & Richard R. Schmidt. 2010. Carbohydrate Chemistry. Carbohydrate Chemistry
64
100
.
L. Wu, C. L. Gabriel, V. V. Parekh & L. Van Kaer. (2009) Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities. Tissue Antigens 73:6, pages 535-545.
Crossref
Crossref
Vrajesh V. Parekh, Saif Lalani, Sungjune Kim, Ramesh Halder, Miyuki Azuma, Hideo Yagita, Vipin Kumar, Lan Wu & Luc Van Kaer. (2009) PD-1/PD-L Blockade Prevents Anergy Induction and Enhances the Anti-Tumor Activities of Glycolipid-Activated Invariant NKT Cells. The Journal of Immunology 182:5, pages 2816-2826.
Crossref
Crossref